Clear Creek Financial Management’s Pfizer PFE Stock Holding History

Clear Creek Financial Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$292K	Sell	12,112 -991	-8%	-$25.9K	0.02%	532
2026 Q1	$368K	Sell	13,103 -1,035	-7%	-$27.6K	0.03%	455
2025 Q4	$352K	Sell	14,138 -573	-4%	-$14.4K	0.03%	461
2025 Q3	$375K	Sell	14,711 -505	-3%	-$12.5K	0.03%	426
2025 Q2	$369K	Buy	15,216 +48	+0.3%	+$1.12K	0.04%	403
2025 Q1	$384K	Sell	15,168 -4,701	-24%	-$123K	0.04%	351
2024 Q4	$527K	Sell	19,869 -22,336	-53%	-$606K	0.06%	287
2024 Q3	$1.22M	Sell	42,205 -500	-1%	-$14.6K	0.14%	149
2024 Q2	$1.2M	Buy	42,705 +1,982	+5%	+$54.6K	0.15%	136
2024 Q1	$1.13M	Buy	40,723 +5,851	+17%	+$162K	0.15%	131
2023 Q4	$1.01M	Buy	34,872 +5,846	+20%	+$177K	0.16%	110
2023 Q3	$964K	Buy	29,026 +7,044	+32%	+$249K	0.17%	104
2023 Q2	$806K	Buy	21,982 +1,538	+8%	+$59.9K	0.14%	119
2023 Q1	$834K	Buy	20,444 +1,157	+6%	+$50K	0.16%	115
2022 Q4	$988K	Sell	19,287 -558	-3%	-$26.8K	0.22%	92
2022 Q3	$868K	Sell	19,845 -4,504	-18%	-$219K	0.19%	90
2022 Q2	$1.28M	Buy	24,349 +7,617	+46%	+$388K	0.27%	76
2022 Q1	$866K	Sell	16,732 -344	-2%	-$17.8K	0.14%	133
2021 Q4	$1.01M	Sell	17,076 -3,155	-16%	-$156K	0.15%	121
2021 Q3	$870K	Sell	20,231 -13,057	-39%	-$578K	0.14%	143
2021 Q2	$1.3M	Buy	33,288 +23,610	+244%	+$918K	0.2%	113
2021 Q1	$376K	Sell	9,678 -22,267	-70%	-$791K	0.75%	33
2020 Q4	$1.18M	Buy	+31,945	New	+$1.17M	0.23%	100
2020 Q3	–	Sell	-17,743	Closed	-$550K	–	209
2020 Q2	$550K	Buy	17,743 +2,736	+18%	+$93K	0.14%	109
2020 Q1	$508K	Buy	15,007 +97	+0.7%	+$3.31K	0.19%	77
2019 Q4	$564K	Sell	14,910 -5,147	-26%	-$183K	0.22%	56
2019 Q3	$691K	Buy	20,057 +2,704	+16%	+$98.3K	0.33%	41
2019 Q2	$713K	Buy	+17,353	New	+$689K	0.31%	47

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Clear Creek Financial Management's PFE Position: Q2 2026 in Review

Clear Creek Financial Management reduced its Pfizer (PFE) stake by 7.6% in Q2 2026, selling an estimated $25.9K and leaving 12,112 shares worth $292K. The position accounts for 0.02% of the portfolio, ranked #532.

Clear Creek Financial Management first reported a position in PFE in Q2 2019 and has held it in 28 quarters since. The position peaked at $1.3M in Q2 2021. 1,179 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Clear Creek Financial Management held 12,112 shares of Pfizer worth $292K as of Q2 2026.
Clear Creek Financial Management sold 991 Pfizer shares in Q2 2026, an estimated $25.9K.
Pfizer made up 0.02% of Clear Creek Financial Management's portfolio in Q2 2026, its #532 holding.
Clear Creek Financial Management first reported a position in Pfizer in Q2 2019 and has held it in 28 quarters since.
Clear Creek Financial Management's Pfizer position peaked at $1.3M in Q2 2021.
1,179 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Clear Creek Financial Management's 13F filing for Q2 2026, filed 28 Jul 2026.